BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan A, Wang B, Wang X, Nie Y, Fan D, Zhao X, Lu Y. Immunotherapy in colorectal cancer: current achievements and future perspective. Int J Biol Sci 2021;17:3837-49. [PMID: 34671202 DOI: 10.7150/ijbs.64077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Jiang X, Zhao Z. Inhibition or promotion, the potential role of arginine metabolism in immunotherapy for colorectal cancer. All Life 2023;16. [DOI: 10.1080/26895293.2022.2163306] [Reference Citation Analysis]
2 Xiao Y, Zhu T, Zeng Q, Tan Q, Jiang G, Huang X. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy. Acta Biomater 2023;157:451-66. [PMID: 36442821 DOI: 10.1016/j.actbio.2022.11.043] [Reference Citation Analysis]
3 San-román-gil M, Torres-jiménez J, Pozas J, Esteban-villarrubia J, Albarrán-fernández V, Álvarez-ballesteros P, Chamorro-pérez J, Rosero-rodríguez D, Orejana-martín I, Martínez-delfrade Í, Reguera-puertas P, Fuentes-mateos R, Ferreiro-monteagudo R. Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma. Cancers 2023;15:863. [DOI: 10.3390/cancers15030863] [Reference Citation Analysis]
4 Cao Y, Zheng X, Hu Y, Li J, Huang B, Zhao N, Liu T, Cai K, Tian S. Levels of systemic inflammation response index are correlated with tumor-associated bacteria in colorectal cancer. Cell Death Dis 2023;14:69. [PMID: 36717544 DOI: 10.1038/s41419-023-05602-9] [Reference Citation Analysis]
5 Gao X, Zhou S, Qin Z, Li D, Zhu Y, Ma D. Upregulation of HMGB1 in tumor-associated macrophages induced by tumor cell-derived lactate further promotes colorectal cancer progression. J Transl Med 2023;21:53. [PMID: 36709284 DOI: 10.1186/s12967-023-03918-w] [Reference Citation Analysis]
6 Sun Q, Wu J, Zhu G, Li T, Zhu X, Ni B, Xu B, Ma X, Li J. Lactate-related metabolic reprogramming and immune regulation in colorectal cancer. Front Endocrinol 2023;13. [DOI: 10.3389/fendo.2022.1089918] [Reference Citation Analysis]
7 Zhou H, Wang Y, Zhang Z, Xiong L, Liu Z, Wen Y. A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy. Front Genet 2022;13:975404. [PMID: 36699444 DOI: 10.3389/fgene.2022.975404] [Reference Citation Analysis]
8 Zhang Y, Zhang Z, Wei L, Wei S. Construction and validation of nomograms combined with novel machine learning algorithms to predict early death of patients with metastatic colorectal cancer. Front Public Health 2022;10:1008137. [PMID: 36605237 DOI: 10.3389/fpubh.2022.1008137] [Reference Citation Analysis]
9 Dazio G, Epistolio S, Frattini M, Saletti P. Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer. J Clin Med 2022;11. [PMID: 36556139 DOI: 10.3390/jcm11247523] [Reference Citation Analysis]
10 Li T, Qian C, Gu Y, Zhang J, Li S, Xia N. Current progress in the development of prophylactic and therapeutic vaccines. Sci China Life Sci 2022;:1-32. [PMID: 36469218 DOI: 10.1007/s11427-022-2230-4] [Reference Citation Analysis]
11 Zhang X, Zhang L, Lai J, Lu Y, Ye J, Wang Y. Screening and identification of hub gene and differential gene and mutation sequence analysis of related genes in colorectal cancer based on bioinformatics analysis. J Gastrointest Oncol 2022;13:3056-66. [PMID: 36636081 DOI: 10.21037/jgo-22-1131] [Reference Citation Analysis]
12 Li C, Yu F, Xu W. Efficacy and safety of camrelizumab plus apatinib compared to apatinib monotherapy as third-line or above therapy for metastatic colorectal cancer patients: A retrospective cohort study. J Clin Pharm Ther 2022;47:2325-34. [PMID: 36495117 DOI: 10.1111/jcpt.13803] [Reference Citation Analysis]
13 Meng Q, Yu Y, Wang K, Zhang Z, Zhao J, Wang Y, Hao D, Wang G. The prognostic role of fasting plasma glucose levels on survival in advanced colorectal cancer patients with type II diabetes mellitus: a retrospective cohort study. J Gastrointest Oncol 2022;13:3080-9. [PMID: 36636046 DOI: 10.21037/jgo-22-1124] [Reference Citation Analysis]
14 Luo HY, Tang WL, Xiang L, Peng LL, Wu DB, Zhu ZY, Gu HT, Tang YH, Perkins RS, Shen HY, Wang YX. Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer. J Gastrointest Oncol 2022;13:3025-37. [PMID: 36636093 DOI: 10.21037/jgo-22-1060] [Reference Citation Analysis]
15 Wang Q, Huang X, Zhou S, Ding Y, Wang H, Jiang W, Xu M. IL1RN and PRRX1 as a Prognostic Biomarker Correlated with Immune Infiltrates in Colorectal Cancer: Evidence from Bioinformatic Analysis. International Journal of Genomics 2022;2022:1-24. [DOI: 10.1155/2022/2723264] [Reference Citation Analysis]
16 Li Y, Hua R, He J, Zhang H. Survival Contradiction in Stage II, IIIA, And IIIB Colon Cancer: A Surveillance, Epidemiology, and End Result-Based Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-8. [DOI: 10.1155/2022/4088117] [Reference Citation Analysis]
17 Zhang Y, Zhang Q, Han X, Han L, Wang T, Hu J, Li L, Ding Z, Shi X, Qian X. SLAMF8, a potential novel immune checkpoint molecule, is associated with the prognosis of colorectal cancer.. [DOI: 10.21203/rs.3.rs-2239673/v1] [Reference Citation Analysis]
18 Jiang H, Yang B, Jiang Y, Liu X, Chen D, Long F, Yang Z, Tang D. Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1025397] [Reference Citation Analysis]
19 Yu Z, Tong S, Wang C, Wu Z, Ye Y, Wang S, Jiang K. PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis. Front Bioeng Biotechnol 2022;10:1001994. [DOI: 10.3389/fbioe.2022.1001994] [Reference Citation Analysis]
20 Yang Z, Wu G, Zhang X, Gao J, Meng C, Liu Y, Wei Q, Sun L, Wei P, Bai Z, Yao H, Zhang Z. Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer. Front Immunol 2022;13:1001444. [DOI: 10.3389/fimmu.2022.1001444] [Reference Citation Analysis]
21 Zheng J, Xie Z, Niu L, Zheng G, Li R, Dan H, Duan L, Wu H, Ren G, Dou X, Feng F, Zhang J. SPP1+ macrophages: A malignant macrophage subset in the colorectal cancer microenvironment revealed by single-cell sequencing.. [DOI: 10.21203/rs.3.rs-1984416/v1] [Reference Citation Analysis]
22 Fu Y, Li F, Sun X, Zhu C, Fan B, Zhong K. KIF4 enforces the progression of colorectal cancer by inhibiting the autophagy via activating the Hedgehog signaling pathway. Archives of Biochemistry and Biophysics 2022. [DOI: 10.1016/j.abb.2022.109423] [Reference Citation Analysis]
23 Zhou Z, Song Q, Yang Y, Wang L, Wu Z. Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer. Cancers (Basel) 2022;14:2938. [PMID: 35740608 DOI: 10.3390/cancers14122938] [Reference Citation Analysis]
24 Yan H, Li Y, Wang X, Qian J, Xu M, Peng J, Huang D. The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry. Front Oncol 2022;12:867658. [DOI: 10.3389/fonc.2022.867658] [Reference Citation Analysis]
25 Ma L, Ma J, Teng M, Li Y. Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021. Front Immunol 2022;13:843106. [PMID: 35432385 DOI: 10.3389/fimmu.2022.843106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
26 Boukouris AE, Theochari M, Stefanou D, Papalambros A, Felekouras E, Gogas H, Ziogas DC. Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update. Crit Rev Oncol Hematol 2022;:103663. [PMID: 35351582 DOI: 10.1016/j.critrevonc.2022.103663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Hartimath SV, Ramasamy B, Xuan TY, Rong TJ, Khanapur S, Cheng P, Hwang YY, Robins EG, Goggi JL. Granzyme B PET Imaging in Response to In Situ Vaccine Therapy Combined with αPD1 in a Murine Colon Cancer Model. Pharmaceutics 2022;14:150. [PMID: 35057046 DOI: 10.3390/pharmaceutics14010150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]